Atlas Trials

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

Clinical trial NCT01921998 · SUSPENDED

Trial details

NCT number
NCT01921998
Sponsor
The Christie NHS Foundation Trust
Status
SUSPENDED
Study type
OBSERVATIONAL
LymphomaSarcoma
Start date
2013-10-01
Primary completion
2015-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.